Mohammed D, Matts P J, Hadgraft J, Lane M E
Department of Pharmaceutics, School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK.
Pharm Res. 2014 Feb;31(2):394-400. doi: 10.1007/s11095-013-1169-2. Epub 2013 Aug 14.
In vitro skin permeation studies have been used extensively in the development and optimisation of delivery of actives in vivo. However, there are few reported correlations of such in vitro studies with in vivo data. The aim of this study was to investigate the skin permeation of a model active, niacinamide, both in vitro and in vivo.
Conventional diffusion cell studies were conducted in human skin to determine niacinamide permeation from a range of vehicles which included dimethyl isosorbide (DMI), propylene glycol (PG), propylene glycol monolaurate (PGML), N-methyl 2-pyrrolidone (NMP), Miglyol 812N® (MG), and mineral oil (MO). Single, binary or ternary systems were examined. The same vehicles were subsequently examined to investigate niacinamide delivery in vivo. For this proof-of-concept study one donor was used for the in vitro studies and one volunteer for the in vivo investigations to minimise biovariability. Analysis of in vitro samples was conducted using HPLC and in vivo uptake of niacinamide was evaluated using Confocal Raman spectroscopy (CRS).
The amount of niacinamide permeated through skin in vitro was linearly proportional to the intensity of the niacinamide signal determined in the stratum corneum in vivo. A good correlation was observed between the signal intensities of selected vehicles and niacinamide signal intensity.
The findings provide further support for the use of CRS to monitor drug delivery into and across the skin. In addition, the results highlight the critical role of the vehicle and its disposition in skin for effective dermal delivery.
体外皮肤渗透研究已广泛应用于活性成分体内递送的开发和优化。然而,此类体外研究与体内数据之间的相关性报道较少。本研究的目的是在体外和体内研究模型活性成分烟酰胺的皮肤渗透情况。
在人体皮肤中进行传统扩散池研究,以确定烟酰胺从一系列载体中的渗透情况,这些载体包括二甲基异山梨醇(DMI)、丙二醇(PG)、丙二醇单月桂酸酯(PGML)、N-甲基-2-吡咯烷酮(NMP)、Miglyol 812N®(MG)和矿物油(MO)。研究了单一、二元或三元体系。随后对相同的载体进行体内烟酰胺递送研究。在这个概念验证研究中,使用一名供体进行体外研究,一名志愿者进行体内研究,以尽量减少生物变异性。使用高效液相色谱法对体外样品进行分析,并使用共聚焦拉曼光谱法(CRS)评估体内烟酰胺的摄取情况。
体外透过皮肤的烟酰胺量与体内角质层中测定的烟酰胺信号强度呈线性比例关系。观察到所选载体的信号强度与烟酰胺信号强度之间具有良好的相关性。
这些发现为使用CRS监测药物进入和穿过皮肤的递送提供了进一步的支持。此外,结果突出了载体及其在皮肤中的分布对有效透皮递送的关键作用。